Work

Phase 2 Trial of G-CSF Priming, Clofarabine, and High Dose Cytarabine (GCLAC) for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) or Advanced Myelodysplastic Syndrome or Advanced Myeloproliferative Neoplasm,

Year: 2011

Type: article

Source: Blood

DOI: 10.1182/blood.v118.21.3617.3617

Authors: Pamela S Becker, Bruno C. Medeiros, Frederick R. Appelbaum, Bart Lee Scott, Paul C. Hendrie, Barry Storer, Sherry Pierce, Stephen H. Petersdorf, Elihu H. Estey

Institutions: University of Washington, Stanford Medicine, Stanford University, Fred Hutch Cancer Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2549459820

FWCI:

Cites:

Cited by:

Related to: 10